Lactic acid bacteria as oral delivery systems for biomolecules

Pharmazie

Volumn 67, Issue 11, 2012, Pages 891-898

  Berlec, A ^a   Ravnikar, M ^b   Štrukelj, Borut ^a,b  

^a JO EF STEFAN INSTITUTE   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; ALPHA2B INTERFERON; BACTERIAL VECTOR; BETA LACTOGLOBULIN; DNA; ENTEROTOXIN; ENVELOPE PROTEIN; FIBROBLAST GROWTH FACTOR 10; HEAT SHOCK PROTEIN; HYBRID PROTEIN; INTERLEUKIN 10; LYMPHOTOXIN; M PROTEIN; NUCLEOCAPSID PROTEIN; OVALBUMIN; OXYNTOMODULIN; PROBIOTIC AGENT; RIBOSOME PROTEIN; TETANUS TOXIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ALLERGY; BACTERIAL COLONIZATION; BACTERICIDAL ACTIVITY; BACTERIUM ADHERENCE; BIFIDOBACTERIUM LONGUM; CARBOHYDRATE METABOLISM; CARNOBACTERIUM; CELL MEMBRANE PERMEABILITY; DENDRITIC CELL; DNA MODIFICATION; DRUG DELIVERY SYSTEM; ENTERITIS; ENTEROCOCCUS; FOOD INDUSTRY; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; LACTIC ACID BACTERIUM; LACTOBACILLUS; LACTOCOCCUS; LACTOCOCCUS LACTIS; LEUCONOSTOC; MACROPHAGE; MOLECULAR WEIGHT; NONHUMAN; OBESITY; OENOCOCCUS; PANCREAS INSUFFICIENCY; PEDIOCOCCUS; PHASE 1 CLINICAL TRIAL (TOPIC); REVIEW; STOMACH LYMPHOMA; STREPTOCOCCUS; TETRAGENOCOCCUS; ULCERATIVE COLITIS; VACCINATION; VIRUS INFECTION;

BACTERIA; BIOLOGICAL FACTORS; DNA; DRUG DELIVERY SYSTEMS; GENETIC THERAPY; HUMANS; INTESTINES; LACTIC ACID; LACTOBACILLUS; LACTOCOCCUS; PROTEINS; VACCINES;

EID: 84869054314     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2012.1705     Document Type: Review

References (99)

1. Alander M, Korpela R, Saxelin M, Vilpponen-Salmela T, Mattila-Sandholm T, von Wright A (1997) Recovery of Lactobacillus rhamnosus GG from human colonic biopsies. Lett Appl Microbiol 24: 361-364. (Pubitemid 27239552)
2. Antosova Z, Mackova M, Kral V, Macek T (2009) Therapeutic application of peptides and proteins: parenteral forever?Trends Biotechnol 27: 628-635.
3. Audouy SA, van Selm S, van Roosmalen ML, Post E, Kanninga R, Neef J, Estevão S, Nieuwenhuis EE, Adrian PV, Leenhouts K, Hermans PW (2007) Development of lactococcal GEM-based pneumococcal vaccines. Vaccine 25: 2497-2506. (Pubitemid 46366131)
4. Bahey-El-Din M, Gahan GM (2010) Lactococcus lactis: from the dairy industry to antigen and therapeutic protein delivery. Discov Med 9: 455-461.
5. Berlec A, Strukelj B (2009) Novel applications of recombinant lactic acid bacteria in therapy and in metabolic engineering. Recent Pat Biotechnol 3: 77-87.
6. Bermúdez-Humarán LG, Cortes-Perez NG, Lefèvre F, Guimarães V, Rabot S, Alcocer-Gonzalez JM, Gratadoux JJ, Rodriguez-Padilla C, Tamez-Guerra RS, Corthier G, Gruss A, Langella P (2005) A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors. J Immunol 175: 7297-7302.
7. Bezkorovainy A (2001) Probiotics: determinants of survival and growth in the gut. Am J Clin Nutr 73(suppl) 399S-405S.
8. Bolotin A, Wincker P, Mauger S, Jaillon O, Malarme K, Weissenbach J, Ehrlich SD, Sorokin A (2001) The complete genome sequence of the lactic acid bacterium Lactococcus lactis ssp. lactis IL1403. Genome Res 11: 731-753. (Pubitemid 32447860)
9. Braat H, Rottiers P, Hommes DW, Huyghebaert N, Remaut E, Remon JP, van Deventer SJ, Neirynck S, Peppelenbosch MP, Steidler L (2006) A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin Gastroenterol Hepatol 4: 754-759. (Pubitemid 43841860)
10. Buccato S, Maione D, Rinaudo CD,Volpini G, Taddei AR, Rosini R, Telford JL, Grandi G, Margarit I (2006) Use of Lactococcus lactis expressing pili from group B Streptococcus as a broad-coverage vaccine against streptococcal disease. J Infect Dis 194: 331-340. (Pubitemid 44116975)
11. Carroll IM, Andrus JM, Bruno-Bárcena JM, Klaenhammer TR, Hassan HM, Threadgill DS (2007) Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. Am J Physiol Gastrointest Liver Physiol 293: G729-738. (Pubitemid 47605922)
12. Charng YC, Lin CC, Hsu CH (2006) Inhibition of allergen-induced airway inflammation and hyperreactivity by recombinant lactic-acid bacteria. Vaccine 24: 5931-5936. (Pubitemid 44096967)
13. Chatel JM, Pothelune L, Ah-Leung S, Corthier G, Wal JM, Langella P (2008) In vivo transfer of plasmid from food-grade transiting lactococci to murine epithelial cells. Gene Ther 15: 1184-1190.
14. Cheung QC, Yuan Z, Dyce PW, Wu D, DeLange K, Li J (2009) Generation of epidermal growth factor-expressing Lactococcus lactis and its enhancement on intestinal development and growth of early-weaned mice. Am J Clin Nutr 89: 871-879.
15. Corthesy B, Boris S, Isler P, Grangette C, Mercenier A (2005) Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis. J Infect Dis 192: 1441-1449. (Pubitemid 41401159)
16. Daniel C, Repa A, Wild C, Pollak A, Pot B, Breiteneder H,Wiedermann U, Mercenier A (2006) Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1. Allergy 61: 812-819. (Pubitemid 43893983)
17. Daniel C, Sebbane F, Poiret S, Goudercourt D, Dewulf J, Mullet C, Simonet M, Pot B (2009) Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV. Vaccine 27: 1141-1144.
18. Davis SS (2001) Nasal vaccines. Adv Drug Deliv Rev 51: 21-42.
19. del Rio B, Seegers JF, Gomes-Solecki M (2010) Immune response to Lactobacillus plantarum expressing Borrelia burgdorferi OspA is modulated by the lipid modification of the antigen. PLoS One 5: e11199.
20. de Vos WM (1999) Gene expression systems for lactic acid bacteria. Curr Opin Microbiol 2: 289-295.
21. de Vrese M, Schrezenmeir J (2008) Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol 111: 1-66.
22. Dicks LMT, Botes M (2010) Probiotic lactic acid bacteria in the gastrointestinal tract: health benefits, safety and mode of action. Beneficial Microbes 1: 11-29.
23. Di-Qiu L, Xin-Yuan Q, Jun-Wei G, Li-Jie T, Yan-Ping J, Yi-Jing L (2011) Construction and characterization of Lactobacillus pentosus expressing the D antigenic site of the spike protein of Transmissible gastroenteritis virus. Can J Microbiol 57: 392-397.
24. Drouault S, Corthier G, Ehrlich SD, Renault P (1999) Survival, physiology, and lysis of Lactococcus lactis in the digestive tract. Appl Environ Microbiol 65: 4881-4886.
25. Drouault S, Juste C, Marteau P, Renault P, Corthier G (2002) Oral treatment with Lactococcus lactis expressing Staphylococcus hyicus lipase enhances lipid digestion in pigs with induced pancreatic insufficiency. Appl Environ Microbiol 68: 3166-3168. (Pubitemid 34602050)
26. Foligne B, Dessein R, Marceau M, Poiret S, Chamaillard M, Pot B, Simonet M, Daniel C (2007) Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein. Gastroenterology 133: 862-874. (Pubitemid 47374132)
27. Fredriksen L, Mathiesen G, Sioud M, Eijsink VG (2010) Cell wall anchoring of the 37-kilodalton oncofetal antigen by Lactobacillus plantarum for mucosal cancer vaccine delivery. Appl Environ Microbiol 76: 7359-7362.
28. Fujiwara D, Inoue S, Wakabayashi H, Fujii T (2004) The anti-allergic effects of lactic acid bacteria are strain dependent and mediated by effects on both Th1/Th2 cytokine expression and balance. Int Arch Allergy Immunol 135: 205-215. (Pubitemid 39664092)
29. Grangette C, Müller-Alouf H, Geoffroy M, Goudercourt D, Turneer M, Mercenier A (2002) Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence. Vaccine 20: 3304-3309. (Pubitemid 35245814)
30. Guimaraes VD, Gabriel JE, Lefèvre F, Cabanes D, Gruss A, Cossart P, Azevedo V, Langella P (2005) Internalin-expressing Lactococcus lactis is able to invade small intestine of guinea pigs and deliver DNA into mammalian epithelial cells. Microbes Infect 7: 836-844. (Pubitemid 40826649)
31. Guimaraes VD, Innocentin S, Lefèvre F, Azevedo V, Wal JM, Langella P, Chatel JM (2006) Use of native lactococci as vehicles for delivery of DNA into mammalian epithelial cells. Appl Environ Microbiol 72: 7091-7097. (Pubitemid 44748422)
32. Hamady ZZ, Scott N, Farrar MD, Wadhwa M, Dilger P, Whitehead TR, Thorpe R, Holland KT, Lodge JP, Carding SR (2010) Treatment of colitis with a commensal gut bacterium engineered to secrete human tgf-β1 under the control of dietary xylan 1. Inflamm Bowel Dis 17: 925-1935.
33. Hamady ZZ, Scott N, Farrar MD, Lodge JP, Holland KT, Whitehead T, Carding SR (2010) Xylan-regulated delivery of human keratinocyte growth factor-2 to the inflamed colon by the human anaerobic commensal bacterium Bacteroides ovatus. Gut 59: 461-469.
34. Hanniffy SB, Carter AT, Hitchin E, Wells JM (2007) Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection. J Infect Dis 195: 185-193. (Pubitemid 46080050)
35. Hazebrouck S, Oozeer R, Adel-Patient K, Langella P, Rabot S, Wal JM, Corthier G (2006) Constitutive delivery of bovine beta-lactoglobulin to the digestive tracts of gnotobiotic mice by engineered Lactobacillus casei. Appl Environ Microbiol 72: 7460-7467. (Pubitemid 44927645)
36. Ho PS, Kwang J, Lee YK (2005) Intragastric administration of Lactobacillus casei expressing transmissible gastroentritis coronavirus spike glycoprotein induced specific antibody production. Vaccine 23: 1335-1342. (Pubitemid 40127325)
37. Hooper LV, Macpherson AJ (2010) Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 10: 159-169.
38. Hu B, Kou L, Li C, Zhu LP, Fan YR, Wu ZW, Wang JJ, Xu GX (2009) Bifidobacterium longum as a delivery system of TRAIL and endostatin cooperates with chemotherapeutic drugs to inhibit hypoxic tumor growth. Cancer Gene Ther 16: 655-663.
39. Huibregtse IL, Marietta EV, Rashtak S, Koning F, Rottiers P, David CS, van Deventer SJ, Murray JA (2009) Induction of antigen-specific tolerance by oral administration of Lactococcus lactis delivered immunodominant DQ8-restricted gliadin peptide in sensitized nonobese diabetic Abo Dq8 transgenic mice. J Immunol 183: 2390-2396.
40. Huibregtse IL, Snoeck V, de Creus A, Braat H, De Jong EC, Van Deventer SJ, Rottiers P (2007) Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin. Gastroenterology 133: 517-528. (Pubitemid 47187339)
41. Iwaki M, Okahashi N, Takahashi I, Kanamoto T, Sugita-Konishi Y, Aibara K, Koga T (1990) Oral immunization with recombinant Streptococcus lactis carrying the Streptococcus mutans surface protein antigen gene. Infect Immun 58: 2929-2934. (Pubitemid 20267682)
42. Johansson ME, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC (2008) The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci USA 105: 15064-15069.
43. Kandler O (1983) Carbohydrate metabolism in lactic acid bacteria. Antonie Van Leeuwenhoek 49: 209-224.
44. Krüger C, Hultberg A, van Dollenweerd C, Marcotte H, Hammarström L (2005) Passive immunization by lactobacilli expressing single-chain antibodies against Streptococcus mutans. Mol Biotechnol 31: 221-231.
45. Lavelle EC, O'Hagan DT (2006) Delivery systems and adjuvants for oral vaccines. Expert Opin Drug Deliv 3: 747-762. (Pubitemid 44781847)
46. LeBlanc JG, Burgess C, Sesma F, de Giori GS, van Sinderen D (2005) Lactococcus lactis is capable of improving the riboflavin status in deficient rats. Br J Nutr 94: 262-267. (Pubitemid 41357798)
47. LeBlanc JG, Sybesma W, Starrenburg M, Sesma F, de Vos WM, de Giori GS, Hugenholtz J (2010) Supplementation with engineered Lactococcus lactis improves the folate status in deficient rats. Nutrition 26: 835-841.
48. Lee P, Abdul-Wahid A, Faubert GM (2009) Comparison of the local immune response against Giardia lamblia cyst wall protein 2 induced by recombinant Lactococcus lactis and Streptococcus gordonii. Microbes Infect 11: 20-28.
49. Lee MH, Roussel Y, Wilks M, Tabaqchali S (2001) Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice. Vaccine 19: 3927-3935. (Pubitemid 32566316)
50. Lee JS, Poo H, Han DP, Hong SP, Kim K, ChoMW, Kim E, Sung MH, Kim CJ (2006) Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice. J Virol 80: 4079-4087.
51. Lei H, Sheng Z, Ding Q, Chen J, Wei X, Lam DM, Xu Y (2011) Evaluation of Oral Immunization with Recombinant Avian Influenza Virus HA1 Displayed on the Lactococcus lactis Surface and Combined with the Mucosal Adjuvant Cholera Toxin Subunit B. Clin Vaccine Immunol 18: 1046-1051.
52. Lei H, Xu Y, Chen J, Wei X, Lam DM (2010) Immunoprotection against influenza H5N1 virus by oral administration of enteric-coated recombinant Lactococcus lactis mini-capsules. Virology 407: 319-324.
53. Li YG, Tian FL, Gao FS, Tang XS, Xia C (2007) Immune responses generated by Lactobacillus as a carrier in DNA immunization against foot-and-mouth disease virus. Vaccine 25: 902-911.
54. Long RT, Zeng WS, Chen LY, Guo J, Lin YZ, Huang QS, Luo SQ (2010) Bifidobacterium as an oral delivery carrier of oxyntomodulin for obesity therapy: inhibitory effects on food intake and body weight in overweight mice. Int J Obes 34: 712-719.
55. Mannam P, Jones KF, Geller BL (2004) Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes. Infect Immun 72: 3444-3450. (Pubitemid 38697770)
56. Marteau P, Minekus M, Havenaar R, Huis in't Veld JH (1997) Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effects of bile. J Dairy Sci 80: 1031-1037. (Pubitemid 127447084)
57. Mohamadzadeh M, Duong T, Sandwick SJ, Hoover T, Klaenhammer TR (2009) Dendritic cell targeting of Bacillus anthracis protective antigen expressed by Lactobacillus acidophilus protects mice from lethal challenge. Proc Natl Acad Sci U S A 106: 4331-4336.
58. Norton PM, Brown HW, Wells JM, Macpherson AM, Wilson PW, Le Page RW (1996) Factors affecting the immunogenicity of tetanus toxin fragment C expressed in Lactococcus lactis. FEMS Immunol Med Microbiol 14: 167-177. (Pubitemid 26186268)
59. Nouaille S, Ribeiro LA, Miyoshi A, Pontes D, Le Loir Y, Oliveira SC, Langella P, Azevedo V (2003) Heterologous protein production and delivery systems for Lactococcus lactis. Genet Mol Res 2: 102-111. (Pubitemid 38846553)
60. Oozeer R, Leplingard A, Mater DD, Mogenet A, Michelin R, Seksek I, Marteau P, Doré J, Bresson JL, Corthier G. (2006) Survival of Lactobacillus casei in the human digestive tract after consumption of fermented milk. Appl Environ Microbiol 72: 5615-5617.
61. Oliveira ML, Areas AP, Campos IB, Monedero V, Perez-Martínez G, Miyaji EN, Leite LC, Aires KA, Lee Ho P (2006) Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A. Microbes Infect 8: 1016-1024.
62. Paul G, Khare V, Gasche C (2011) Inflamed gut mucosa: downstream of interleukin-10. Eur J Clin Invest. Epub ahead of print.
63. Perez CA, Eichwald C, Burrone O, MendozaD(2005) Rotavirus vp7 antigen produced by Lactococcus lactis induces neutralizing antibodies in mice. J Appl Microbiol 99: 1158-1164. (Pubitemid 41531306)
64. Perdigón G, Fuller R, Raya R (2001) Lactic acid bacteria and their effect on the immune system. Curr Issues Intest Microbiol 2: 27-42. (Pubitemid 32401085)
65. Pontes DS, Dorella FA, Ribeiro LA, Miyoshi A, Le LoirY, Gruss A, Oliveira SC, Langella P, Azevedo V (2003) Induction of partial protection in mice after oral administration of Lactococcus lactis producing Brucella abortus L7/L12 antigen. J Drug Target 11: 489-493. (Pubitemid 38519158)
66. Pouwels PH, Leer RJ, Shaw M, Heijne den Bak-Glashouwer MJ, Tielen FD, Smit E, Martinez B, Jore J, Conway PL (1998) Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes. Int J Food Microbiol 41: 155-167. (Pubitemid 28369429)
67. Ramasamy R, Yasawardena S, Zomer A, Venema G, Kok J, Leenhouts K (2006) Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations. Vaccine 24: 3900-3908.
68. Ramirez K, Ditamo Y, Rodriguez L, Picking WL, van Roosmalen ML, Leenhouts K, Pasetti MF (2010) Neonatal mucosal immunization with a non-living, non-genetically modified Lactococcus lactis vaccine carrier induces systemic and local Th1-type immunity and protects against lethal bacterial infection. Mucosal Immunol 3: 159-171.
69. Ravnikar M, Strukelj B, Obermajer N, Lunder M, Berlec A (2010) Engineered lactic acid bacterium Lactococcus lactis capable of binding antibodies and tumor necrosis factor alpha. Appl Environ Microbiol 76: 6928-6932.
70. Rigaux P, Daniel C, Hisbergues M, Muraille E, Hols P, Pot B, Pestel J, Jacquet A (2009) Immunomodulatory properties of Lactobacillus plantarum and its use as a recombinant vaccine against mite allergy. Allergy 64: 406-414.
71. Robinson K, Chamberlain LM, Schofield KM, Wells JM, Le Page RW (1997) Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nat Biotechnol 15: 653-657. (Pubitemid 27291166)
72. Scavone P, Miyoshi A, Rial A, Chabalgoity A, Langella P, Azevedo V, Zunino P (2007) Intranasal immunisation with recombinant Lactococcus lactis displaying either anchored or secreted forms of Proteus mirabilis MrpA fimbrial protein confers specific immune response and induces a significant reduction of kidney bacterial colonisation in mice. Microbes Infect 9: 821-828. (Pubitemid 46901040)
73. Saluja V, Visser MR, Ter Veer W, van Roosmalen ML, Leenhouts K, Hinrichs WL, Huckriede A, Frijlink HW (2010) Influenza antigen-sparing by immune stimulation with Gram-positive enhancer matrix (GEM) particles. Vaccine 28: 7963-7969.
74. Saluja V, Visser MR, van Roosmalen ML, Leenhouts K, Huckriede A, Hinrichs WL, Frijlink HW (2010) Gastro-intestinal delivery of influenza subunit vaccine formulation adjuvanted with Gram-positive enhancer matrix (GEM) particles. Eur J Pharm Biopharm 76: 470-474.
75. Saluja V, Amorij JP, van Roosmalen ML, Leenhouts K, Huckriede A, Hinrichs WL, Frijlink HW (2010) Intranasal delivery of influenza subunit vaccine formulated with GEM particles as an adjuvant. AAPS J 12: 109-116.
76. Scheppler L, Vogel M, Marti P, Müller L, Miescher SM, Stadler BM (2005) Intranasal immunisation using recombinant Lactobacillus johnsonii as a new strategy to prevent allergic disease. Vaccine 23: 1126-1134. (Pubitemid 40052009)
77. Schwarzer M, Repa A, Daniel C, Schabussova I, Hrncir T, Pot B, Stepankova R, Hudcovic T, Pollak A, Tlaskalova-Hogenova H, Wiedermann U, Kozakova H (2011) Neonatal colonization of mice with Lactobacillus plantarum producing the aeroallergen Bet v 1 biases towards Th1 and T-regulatory responses upon systemic sensitization. Allergy 66: 368-375.
78. Shen WC (2003) Oral peptide and protein delivery: unfulfilled promises? Drug Discov Today 8: 607-608.
79. Steen A, Buist G, Horsburgh GJ, Venema G, Kuipers OP, Foster SJ, Kok J (2005) AcmA of Lactococcus lactis is an N-acetylglucosaminidase with an optimal number of LysM domains for proper functioning. FEBS J 272: 2854-2868. (Pubitemid 40825430)
80. Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, Fiers W, Remaut E (2000) Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289: 1352-1355. (Pubitemid 30656052)
81. Steidler L, Neirynck S, Huyghebaert N, Snoeck V, Vermeire A, Goddeeris B, Cox E, Remon JP, Remaut E (2003) Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat Biotechnol 21: 785-789. (Pubitemid 36791397)
82. Steidler L, Robinson K, Chamberlain L, Schofield KM, Remaut E, Le Page RW, Wells JM (1998) Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine. Infect Immun 66: 3183-3189. (Pubitemid 28303115)
83. Stiedler L, Rottiers P, Coulie B (2009) Actobiotics as a novel method for cytokine delivery. Ann N Y Acad Sci 1182: 135-145.
84. Stiles ME, Holzapfel WH (1997) Lactic acid bacteria of foods and their current taxonomy. Int J Food Microbiol 36: 1-29. (Pubitemid 27198916)
85. van Hylckama Vlieg JE, Rademaker JL, Bachmann H, Molenaar D, Kelly WJ, Siezen RJ (2006) Natural diversity and adaptive responses of Lactococcus lactis. Curr Opin Biotechnol 17: 183-190.
86. van Roosmalen ML, Kanninga R, El Khattabi M, Neef J, Audouy S, Bosma T, Kuipers A, Post E, Steen A, Kok J, Buist G, Kuipers OP, Robillard G, Leenhouts K (2006) Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria. Methods 38: 144-149. (Pubitemid 43163475)
87. Vandenbroucke K, de Haard H, Beirnaert E, Dreier T, Lauwereys M, Huyck L, Van Huysse J, Demetter P, Steidler L, Remaut E, Cuvelier C, Rottiers P (2010) Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis. Mucosal Immunol 3: 49-56.
88. Vandenbroucke K, Hans W, Van Huysse J, Neirynck S, Demetter P, Remaut E, Rottiers P, Steidler L (2004) Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice. Gastroenterology 127: 502-513. (Pubitemid 39091899)
89. Verna EC, Lucak S (2010) Use of probiotics in gastrointestinal disorders. Ther Adv Gastroenterol 3: 307-319.
90. Wei CH, Liu JK, Hou XL, Yu LY, Lee JS, Kim CJ (2010) Immunogenicity and protective efficacy of orally or intranasally administered recombinant Lactobacillus casei expressing ETEC K99. Vaccine 28: 4113-4118.
91. Wells JM, Wilson PW, Norton PM, Gasson MJ, Le Page RW (1993) Lactococcus lactis: high-level expression of tetanus toxin fragment C and protection against lethal challenge. Mol Microbiol 8: 1155-1162. (Pubitemid 23187034)
92. Wells JM, Mercenier A (2008) Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol 6: 349-362. (Pubitemid 351552656)
93. Wu CM, Chung TC (2007) Mice protected by oral immunization with Lactobacillus reuteri secreting fusion protein of Escherichia coli enterotoxin subunit protein. FEMS Immunol Med Microbiol 50: 354-365.
94. Xiang S, Fruehauf J, Li CJ (2006) Short hairpin RNA-expressing bacteria elicit RNA interference in mammals. Nat Biotechnol 24: 697-702. (Pubitemid 43882121)
95. Xin KQ, Hoshino Y, Toda Y, Igimi S, Kojima Y, Jounai N, Ohba K, Kushiro A, Kiwaki M, Hamajima K, Klinman D, Okuda K (2003) Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env. Blood 102: 223-228. (Pubitemid 36759658)
96. Yam KK, Hugentobler F, Pouliot P, Stern AM, Lalande JD, Matlashewski G, Olivier M, Cousineau B (2011) Generation and evaluation of A2-expressing Lactococcus lactis live vaccines against Leishmania donovani in BALB/c mice. J Med Microbiol 60: 1248-1260.
97. Yoon SW, Lee CH, Kim JY, Kim JY, Sung MH, Poo H (2008) Lactobacillus casei secreting alpha-MSH induces the therapeutic effect on DSS-induced acute colitis in Balb/c Mice. J Microbiol Biotechnol 18: 1975-1983.
98. Yu Z, Zeng Z, Huang Z, Lian J, Yang J, Deng Q, Zeng W (2010) Increased mRNA expression of interferon-induced Mx1 and immunomodulation following oral administration of IFN-alpha2b-transformed B. longum to mice. Arch Microbiol 92: 633-638.
99. Zhang Q, Zhong J, Huan L (2011) Expression of hepatitis B virus surface antigen determinants in Lactococcus lactis for oral vaccination. Microbiol Res 166: 111-120.